Pharmacy Times On May 5, 2013, the FDA approved Liptruzet, a combination tablet of ezetimibe/ atorvastatin at 4 different doses of atorvastatin (10, 20, 40, or 80 mg) combined with a 10-mg dose of ezetimibe.1 The combination of these 2 medications is indicated for ...
DailyFinance FUSILEV may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone, and increase the frequency of seizures in susceptible patients. Full prescribing information for FUSILEV can be found at www.FUSILEV.com. About FOLOTYN ®. and more »
Medscape ... the likelihood of hypoglycemia, an effect that is heightened among patients receiving concomitant insulin or sulfonylurea treatment, coauthor Wang Jiun-Lin, MD, from I-Shou University and E-Da Hospital, Kaohsiung, Taiwan, told Medscape Medical News. and more »
Pharmacy Times The study by Patel et al demonstrates that choosing to use an antibiotic that does not inhibit CYP3A4 (eg, azithromycin) is a simple way to avoid the potential interaction with statins that are CYP3A4 substrates. Other antimicrobial agents that inhibit ...
MarketWatch (press release) Decrease the dose of ELIQUIS to 2.5 mg twice daily when coadministered with drugs that are strong dual inhibitors of CYP3A4 and P-gp, (e.g., ketoconazole, itraconazole, ritonavir, or clarithromycin ). In patients already taking ELIQUIS at a dose of 2.5 ... and more »
